NIH renews funding for the Antibacterial Resistance Leadership Group

As antibiotic-resistant bacteria become more urgent threats worldwide, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will provide up to $102.5 million in renewed funding over seven years for the Antibacterial Resistance Leadership Group (ARLG). This global consortium of scientific experts leads a comprehensive clinical research network…

House Votes to Give the Government the Power to Negotiate Drug Prices

WASHINGTON — The House, delivering on one of Democrats’ central campaign promises, passed ambitious legislation on Thursday to lower the rising cost of prescription drugs by empowering the federal government to negotiate prices with pharmaceutical manufacturers. The bill, known as H.R. 3 — a numerical designation that reflects its position on Democrats’ priority list —…